AU2003273247A8 - Non-invasive methods to identify agents for treating pain - Google Patents

Non-invasive methods to identify agents for treating pain

Info

Publication number
AU2003273247A8
AU2003273247A8 AU2003273247A AU2003273247A AU2003273247A8 AU 2003273247 A8 AU2003273247 A8 AU 2003273247A8 AU 2003273247 A AU2003273247 A AU 2003273247A AU 2003273247 A AU2003273247 A AU 2003273247A AU 2003273247 A8 AU2003273247 A8 AU 2003273247A8
Authority
AU
Australia
Prior art keywords
treating pain
identify agents
invasive methods
invasive
identify
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003273247A
Other versions
AU2003273247A1 (en
Inventor
Karl Keiser
Kenneth M Hargreaves
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Texas System
Original Assignee
University of Texas System
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Texas System filed Critical University of Texas System
Publication of AU2003273247A1 publication Critical patent/AU2003273247A1/en
Publication of AU2003273247A8 publication Critical patent/AU2003273247A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5082—Supracellular entities, e.g. tissue, organisms
    • G01N33/5088—Supracellular entities, e.g. tissue, organisms of vertebrates
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/9486—Analgesics, e.g. opiates, aspirine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Emergency Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pain & Pain Management (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2003273247A 2002-08-30 2003-08-27 Non-invasive methods to identify agents for treating pain Abandoned AU2003273247A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US40702502P 2002-08-30 2002-08-30
US60/407,025 2002-08-30
PCT/US2003/026890 WO2004019875A2 (en) 2002-08-30 2003-08-27 Non-invasive methods to identify agents for treating pain

Publications (2)

Publication Number Publication Date
AU2003273247A1 AU2003273247A1 (en) 2004-03-19
AU2003273247A8 true AU2003273247A8 (en) 2004-03-19

Family

ID=31978408

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003273247A Abandoned AU2003273247A1 (en) 2002-08-30 2003-08-27 Non-invasive methods to identify agents for treating pain

Country Status (2)

Country Link
AU (1) AU2003273247A1 (en)
WO (1) WO2004019875A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007025249A2 (en) 2005-08-26 2007-03-01 The Board Of Trustees Of The Leland Stanford Junior University Methods for treatment of headaches by administration of oxytocin
PT3242676T (en) 2015-01-07 2023-12-06 TONIX Pharmaceuticals Holding Corp Magnesium-containing oxytocin formulations and methods of use

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5683725A (en) * 1995-05-25 1997-11-04 Biofrontiers, Inc. Modulation of substance P by compounds containing calcium sulfate and methods relating thereto
EP1290164B1 (en) * 2000-04-07 2006-11-29 Bayer HealthCare AG Human twik-8 molecules and uses thereof

Also Published As

Publication number Publication date
WO2004019875A3 (en) 2006-07-27
AU2003273247A1 (en) 2004-03-19
WO2004019875A2 (en) 2004-03-11

Similar Documents

Publication Publication Date Title
ZA200508744B (en) Therapeutic agents useful for treating pain
EP1636359A4 (en) Methods for treating pain
EP1696877A4 (en) Methods for treating pain
IL209352A0 (en) 4-tetrazolyl-4phenylpiperidine derivatives for treating pain
AU2003286567A8 (en) Methods for the treatment of skin disorders
GB0201850D0 (en) Therapeutic treatment
GB0216321D0 (en) Therapeutic treatment
EP1838714A4 (en) Methods of treating pain
GB0316912D0 (en) Therapeutic treatment
HK1078784A1 (en) Therapeutic treatment
GB0223367D0 (en) Therapeutic treatment
EP1651237A4 (en) Methods for treatment of dermatological conditions
GB0213869D0 (en) The treatment of pain
EP1648399A4 (en) Method and topical composition for the treatment of hyperpigmented skin
GB0211295D0 (en) Treatment of pain
GB0210464D0 (en) Therapeutic treatment
AU2003273247A8 (en) Non-invasive methods to identify agents for treating pain
AU2003275433A8 (en) Compositions and methods for treating pain
GB0702859D0 (en) Dressing for tissue treatment
GB0313772D0 (en) Therapeutic treatment
GB0221712D0 (en) Methods of treatment
GB0211297D0 (en) Pain treatment
GB0310147D0 (en) A composition for use in the treatment of a skin condition in a subject
HK1113139A1 (en) Therapeutic agents useful for treating pain
SI1472225T1 (en) 2-piperazine-pyridines useful for treating pain

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase